Certis Oncology Solutions, Inc.

About

Certis Oncology Solutions, Inc. is a life science technology company focused on precision oncology. Founded in 2016 and based in San Diego, California, Certis collaborates with cancer patients, oncologists, and pharmaceutical companies to enhance cancer treatment and drug development. The company aims to provide certainty in treatment decisions through its innovative scientific approach. Certis offers integrated solutions, including Oncology Intelligence®, which provides predictive therapeutic response data based on a tumor's gene expression profile. Their CertisAI™ Predictive Oncology Intelligence platform is a patented AI/ML tool that predicts drug efficacy by analyzing complex gene signatures. Additionally, the CertisOI Assistant™ is a natural language interface that gives researchers access to extensive genomic and drug sensitivity data from various cancer research models. The company serves physician-scientists, clinical oncologists, and pharmaceutical companies, helping them identify optimal therapies for patients and develop next-generation anticancer treatments. With a strong foundation in orthotopic patient-derived xenograft models and advanced scientific capabilities, Certis is dedicated to advancing the field of oncology.